Hi, you are logged in as , if you are not , please click here
You are shopping as , if this is not your email, please click here

F47 MBI: Vaccine Bioprocess Development & Commercialisation 2024


Event Information

Dates of Event
18th June 2024 – 20th June 2024
Last Booking Date for this Event
14th June 2024


Delivered in collaboration with Massachusetts Institute of Technology (MIT), this course will assist in developing your knowledge on the challenges of creating a vaccine process.

This three-day course will explore the critical issues at the various stages of vaccine development. International experts with over 10 years’ experience in their field will lead delegates in developing their understanding in the research, development, operational and regulatory challenges of the vaccine market. In addition to expert lectures and excellent networking opportunities with your peers, one case study will be conducted during the workshop about manufacturing at-risk with real examples from the influenza manufacturing process.

Topics covered will include:


 Scale-up from lab to pilot scale

 Quality by Design (QbD) as part of vaccine development

 Expression systems

 Single use platforms

 Regulation and its impact on development

 Final formulation and adjuvants

 Developing world needs


The cost of the course includes tuition, course materials, lunches, refreshments and a networking dinner. Accommodation is not included.


Attendee CategoryCost   
Standard Rate.£1750.00[Read More]

How would you rate your experience today?

How can we contact you?

What could we do better?

   Change Code